Related Experiment Videos
Combining radiotherapy and immunotherapy: a revived partnership
Sandra Demaria1, Nina Bhardwaj, William H McBride
1Department of Pathology, New York University School of Medicine, New York, NY 10016, USA.
International Journal of Radiation Oncology, Biology, Physics
|October 4, 2005
Summary
Radiation therapy (RT) kills cancer cells directly but also boosts antitumor immunity by modifying the tumor microenvironment. Combining RT with immunotherapy strategies enhances cancer treatment effectiveness.
Area of Science:
- Oncology
- Immunology
- Radiation Oncology
Background:
- Radiation therapy (RT) is a primary cancer treatment modality.
- Its efficacy is traditionally attributed to direct cytotoxic effects on cancer cells.
- Emerging evidence suggests RT also modulates the tumor microenvironment and immune response.
Purpose of the Study:
- To review the impact of RT on tumor immunity.
- To explore RT's potential as an immunotherapy-inducing agent.
- To propose a novel radioimmunotherapy approach for cancer treatment.
Main Methods:
- Literature review of preclinical studies on RT and tumor immunity.
- Analysis of RT's effects on tumor-associated antigens, antigen-presenting cells, and effector mechanisms.
- Discussion of experimental evidence for RT-induced antitumor immunity.
Main Results:
- RT can induce inflammation and modify the tumor microenvironment.
- RT has the potential to generate effective antitumor immunity.
- Preclinical data support combining RT with immunotherapeutic strategies.
Conclusions:
- RT's effects extend beyond direct cell kill, influencing the immune system.
- RT can be leveraged to enhance antitumor immune responses.
- Combining RT with immunotherapy offers a promising strategy for cancer treatment, termed radioimmunotherapy.